Latest filing published 27 Mar 2026 for 메디쎄이.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -3.1%Entry ₩11,240 · Close at T+90 ₩10,891
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
동화약품: trading record in brief
동화약품 discloses dealings in 2 companies, chiefly 메디쎄이 and 동화약품. In total, 6 filings cover trades dated from 2 May 2022 to 11 March 2026.
Every open-market trade on record is a purchase: 5 purchases worth €237k, and no sale. The amount is not disclosed for 4 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2026: 3 purchases and no sales on the market.
The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.
On 27 March 2026 came the latest disclosure, an open-market purchase in 메디쎄이. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 동화약품
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 87,239 sharesKRXDART:20260327001766Canonical exit: 22 Jun 2025 (T+90)
- 46,719 shares@ ₩8,000.00100.0% of flowShareKRXDART:20260327001795Canonical exit: 24 Jun 2025 (T+90)
- 48,713 sharesKRXDART:20260327001781Canonical exit: 8 Mar 2026 (T+90)
- ShareKRXDART:20220830000439Canonical exit: 28 Nov 2022 (T+90)
- ShareKRXDART:20220502000291Canonical exit: 31 Jul 2022 (T+90)
6 of 6 declarations